ayurvedic management in diabetic retinopathy

OPEN LABEL CLINICAL COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF MAHAVASADIKWATHA INTERNALLY WITH OR WITHOUT HARITAKYADIVARTI ANJANA IN NON PROLIFERATIVE DIABETIC RETINOPATHYâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032831

Enrollment

Registered

2021-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E083- Diabetes mellitus due to underlying condition with ophthalmic complications

Interventions

Intervention1: Mahavasadi kwatha and Haritakyadi varti anjana in group A: Mahavasadi kwatha 50 ml OD orally for 48 daysand Haritakyadi varti anjana once a day for 30 days Control Intervention1: Mahava

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged between 40 to 70 years of either sex. 2.Patients having the classical clinical features of non-proliferative Diabetic Retinopathy. 3.Patients with Controlled blood sugar level.

Exclusion criteria

Exclusion criteria: 1.Other retinal disorders. 2.Other systemic disorders 3.Patients with history of Smoking, alcoholism and drug abuse.

Design outcomes

Primary

Measure	Time frame
Reduced Blurring of vision and Floaters Timepoint: 30 days	—

Secondary

Measure	Time frame
Complete reduced Blurring of vision, floaters and improved lifestyle and health of the patientTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDrVeerayya R Hiremath

Shree Jagadguru gavisidheswara ayurvedic medical college postgraduate studies and research centre

drveerurh@yahoo.co.in9448544376

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026